Eline Suzanne Klaassens
Research Subjects
Eline Suzanne Klaassens has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Mirna Lilian Baak
2 shared publications- Radhika Bongoni
TIAS school for Business and Society, Tilburg University, Tilburg, The Netherlands
2 shared publications - Andre P. van Beek
Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1 shared publication - Anouk Elise Maria Willems
Applied Research Centre Food & Dairy, Van Hall Larenstein University of Applied Sciences, 8934 CJ Leeuwarden, The Netherlands
1 shared publication - Bartholomeus van Den Bogert
Product Development Department, BaseClear B.V., 2333 BE Leiden, The Netherlands
1 shared publication - Chenay Waldekker
Researchgroup Analysis Techniques in the Life Sciences, Centre of Expertise Perspective in Health, Avans University of Applied Sciences, Breda, Netherlands
1 shared publication
Latest Publications
- Open Access
Women’s health outreach using a rapid and fieldable Nanopore-based microbiome profiling workflow
Background: In recent years, scientific interest in the vaginal microbiome has increased due to its impact on women’s health. Colonization of the Lactobacillus species in the vagina may contribute to protection against vaginal infectious diseases. In order to create public awareness regarding vaginal health and to provide insights into the vaginal microbiome, a rapid field microbiome analysis using Nanopore sequencing was evaluated at Lowlands, a three-day music festival in the Netherlands. This study aimed not only to evaluate a rapid sequencing workflow, but also to explore citizen science as a tool for health promotion and public engagement in women’s health. Methods: The workflow at Lowlands contained the following steps; (i) Dialogue concerning vaginal health, with invitation to participate. (ii) Informed consent and questionnaire to investigate knowledge on vaginal health, life-style and contraceptive usage; (iii) self-collection of a vaginal swab; (iv) DNA isolation using QuickExtract DNA extraction solution; (v) Ultrafast amplification of the 16S rRNA gene using NextGenPCR™ thermal cycling using 16S Barcoding kit 24 V14; (vi) Library preparation and sequencing was performed according to the manufacturers protocol using R10 chemistry; (vii) For data-analysis, MABA16S was used, with slight modifications. This workflow was established within 4 hours and results were communicated with interested participants. Results: A total of n=303 people participated in this study within a timeframe of three days, with n=265 samples being analyzed. 35.8% of participants were dominated by L. crispatus , followed by L. iners (26.4%) and L. jensenii (6,4%). Additionally, lifestyle characteristics for Lactobacillus species carriership were investigated, with a statistically significant association found between dominance of Lactobacillus species and the contraceptive used. A knowledge gap was found regarding the awareness of Lactobacillus species in the vagina. Also, the project stimulated dialogue about vaginal health, with participants reporting that the study increased their awareness and ability to talk openly about the topic. Conclusions: This project successfully developed a rapid microbiome analysis capable of mapping the vaginal microbiome within four hours. Additionally, the findings highlight that citizen science-based research can effectively spark important conversations and may help break the taboo surrounding vaginal health. Clinical trial number: not applicable.
Open AccessWomen’s health outreach using a rapid and fieldable Nanopore-based microbiome profiling workflow
Background: In recent years, scientific interest in the vaginal microbiome has increased due to its impact on women’s health. Colonization of the Lactobacillus species in the vagina may contribute to protection against vaginal infectious diseases. In order to create public awareness regarding vaginal health and to provide insights into the vaginal microbiome, a rapid field microbiome analysis using Nanopore sequencing was evaluated at Lowlands, a three-day music festival in the Netherlands. This study aimed not only to evaluate a rapid sequencing workflow, but also to explore citizen science as a tool for health promotion and public engagement in women’s health. Methods: The workflow at Lowlands contained the following steps; (i) Dialogue concerning vaginal health, with invitation to participate. (ii) Informed consent and questionnaire to investigate knowledge on vaginal health, life-style and contraceptive usage; (iii) self-collection of a vaginal swab; (iv) DNA isolation using QuickExtract DNA extraction solution; (v) Ultrafast amplification of the 16S rRNA gene using NextGenPCR™ thermal cycling using 16S Barcoding kit 24 V14; (vi) Library preparation and sequencing was performed according to the manufacturers protocol using R10 chemistry; (vii) For data-analysis, MABA16S was used, with slight modifications. This workflow was established within 4 hours and results were communicated with interested participants. Results: A total of n=303 people participated in this study within a timeframe of three days, with n=265 samples being analyzed. 35.8% of participants were dominated by L. crispatus , followed by L. iners (26.4%) and L. jensenii (6,4%). Additionally, lifestyle characteristics for Lactobacillus species carriership were investigated, with a statistically significant association found between dominance of Lactobacillus species and the contraceptive used. A knowledge gap was found regarding the awareness of Lactobacillus species in the vagina. Also, the project stimulated dialogue about vaginal health, with participants reporting that the study increased their awareness and ability to talk openly about the topic. Conclusions: This project successfully developed a rapid microbiome analysis capable of mapping the vaginal microbiome within four hours. Additionally, the findings highlight that citizen science-based research can effectively spark important conversations and may help break the taboo surrounding vaginal health. Clinical trial number: not applicable.
- Open Access
- 1 January 2025
- Published by Wiley in Advanced Gut & Microbiome Research
- Vol. 2025 (1)
Improved Key Microbial Biomarker Discovery Using Ensemble Statistical Methods
In recent years, there has been a growing awareness of the importance of the microbiome in health and disease. Consequently, the number of large microbiome‐related clinical trials has also significantly increased. However, advanced biostatistical analysis is required to properly combine microbiome taxonomic abundance data with phenotypical metadata and reliably predict disease states. While differential abundance analysis and machine‐learning techniques are widely used to perform such analyses, selecting the best method is not trivial due to the complexity and specific characteristics of both the data and the algorithms. Here, we present a consensus‐based key microbial biomarker (KMB) biostatistical analysis framework that links microbial abundance obtained from amplicon‐based or shotgun metagenome sequencing with metadata. The framework integrates machine learning (ML) algorithms and statistical methods to determine the most relevant microbial biomarkers and signatures that explain variation in the microbial abundance counts and metadata classes based on predefined metrics. We evaluated the performance of our framework on publicly available case‐control datasets of colorectal cancer, Alzheimer’s disease, and Parkinson’s disease and show that, compared to individually run methods, the combined approach is better able to detect KMB species and signatures associated with health and disease conditions. We conclude that our proposed KMB framework provides an innovative and robust strategy that can contribute to the further development of improved diagnostic tools for early disease detection, personalized medicine design, patient stratification, and a better general understanding of the mechanisms behind observed results in pre and postclinical trials.
- 1 January 2025
- Published by Wiley in Advanced Gut & Microbiome Research
- Vol. 2025 (1)
Open AccessImproved Key Microbial Biomarker Discovery Using Ensemble Statistical Methods
In recent years, there has been a growing awareness of the importance of the microbiome in health and disease. Consequently, the number of large microbiome‐related clinical trials has also significantly increased. However, advanced biostatistical analysis is required to properly combine microbiome taxonomic abundance data with phenotypical metadata and reliably predict disease states. While differential abundance analysis and machine‐learning techniques are widely used to perform such analyses, selecting the best method is not trivial due to the complexity and specific characteristics of both the data and the algorithms. Here, we present a consensus‐based key microbial biomarker (KMB) biostatistical analysis framework that links microbial abundance obtained from amplicon‐based or shotgun metagenome sequencing with metadata. The framework integrates machine learning (ML) algorithms and statistical methods to determine the most relevant microbial biomarkers and signatures that explain variation in the microbial abundance counts and metadata classes based on predefined metrics. We evaluated the performance of our framework on publicly available case‐control datasets of colorectal cancer, Alzheimer’s disease, and Parkinson’s disease and show that, compared to individually run methods, the combined approach is better able to detect KMB species and signatures associated with health and disease conditions. We conclude that our proposed KMB framework provides an innovative and robust strategy that can contribute to the further development of improved diagnostic tools for early disease detection, personalized medicine design, patient stratification, and a better general understanding of the mechanisms behind observed results in pre and postclinical trials.
- Open Access
Self-Initiated Dietary Adjustments Alter Microbiota Abundances: Implications for Perceived Health
Background/Objectives: Personalized and self-initiated dietary adjustments have been shown to alleviate mental and somatic complaints. Here, we investigated the potential role of gut microbiome alterations underlying these effects. Methods: For this purpose, participants (n = 185) underwent a four-week self-initiated dietary intervention and filled out weekly questionnaires on their dietary intake, somatic and mental symptoms, and physical activity. Results: Overall, the participants lost weight, had alleviated mental and somatic complaints, reduced their total caloric and percentual carbohydrate intake, and ate less processed, party-type, and traditional Dutch food items, but ate more Pescatarian type food items, while keeping their fiber intake unaltered. Baseline and endpoint gut microbiota analyses using 16S rRNA gene sequencing revealed an overall increase in Gemmiger formicilis and reductions in Peptostreptococcaceae and Ruminococcus bromii over the four-week dietary intervention. While these bacterial alterations were considered to be beneficial for the host, they were not individually correlated with alterations in, or endpoint levels of, somatic and/or mental complaints. Instead, individual increases in Ruminococcus bicirculans (a well-known utilizer of plant cell wall polysaccharides) were strongly correlated with reductions in mental complaints, even though overall R. bicirculans remained unaltered over the course of the four-week self-initiated dierary intervention. Conclusions: Our results suggest that overall altered versus individually correlated microbiota abundances and their relations with host health characteristics over the course of a self-chosen dietary intervention may represent different levels of regulation, which remain to be further untangled.
Open AccessSelf-Initiated Dietary Adjustments Alter Microbiota Abundances: Implications for Perceived Health
Background/Objectives: Personalized and self-initiated dietary adjustments have been shown to alleviate mental and somatic complaints. Here, we investigated the potential role of gut microbiome alterations underlying these effects. Methods: For this purpose, participants (n = 185) underwent a four-week self-initiated dietary intervention and filled out weekly questionnaires on their dietary intake, somatic and mental symptoms, and physical activity. Results: Overall, the participants lost weight, had alleviated mental and somatic complaints, reduced their total caloric and percentual carbohydrate intake, and ate less processed, party-type, and traditional Dutch food items, but ate more Pescatarian type food items, while keeping their fiber intake unaltered. Baseline and endpoint gut microbiota analyses using 16S rRNA gene sequencing revealed an overall increase in Gemmiger formicilis and reductions in Peptostreptococcaceae and Ruminococcus bromii over the four-week dietary intervention. While these bacterial alterations were considered to be beneficial for the host, they were not individually correlated with alterations in, or endpoint levels of, somatic and/or mental complaints. Instead, individual increases in Ruminococcus bicirculans (a well-known utilizer of plant cell wall polysaccharides) were strongly correlated with reductions in mental complaints, even though overall R. bicirculans remained unaltered over the course of the four-week self-initiated dierary intervention. Conclusions: Our results suggest that overall altered versus individually correlated microbiota abundances and their relations with host health characteristics over the course of a self-chosen dietary intervention may represent different levels of regulation, which remain to be further untangled.
- Open Access
- 28 June 2024
- Published by OAE Publishing Inc. in Microbiome Research Reports
- Vol. 3 (3) , 38
Effect of protein modification in synbiotic infant formula on probiotic metabolic activity and bacterial composition in an infant gut-model
Aim: Microbial colonization of the neonatal gut is pivotal in priming the infant’s immune system. Human milk (HM) is the best nutrition for infants and supports the development of the microbiota due to prebiotic compounds and probiotic microorganisms. When exclusive breastfeeding is not possible, infant formula (IF) with probiotics is a strategy to support the infant’s microbiome development. However, knowledge about the effects of the infant gut microbiota and different compounds in IF on individual probiotic strains is limited, as strain-level detection in a complex ecosystem is challenging. The aim of the present study was to show the effects of IF with different protein forms on the metabolic activity of two probiotic strains isolated from HM in a complex ecosystem. Methods: By using an ex-vivo infant gut model containing infant donor-microbiota, the effects of IF with either intact or extensively hydrolyzed protein on the metabolic activity of the donor microbiota, as well as two probiotic strains [Limosilactobacillus fermentum (L. fermentum ) CECT 5716 (Lf) and Bifidobacterium breve (B. breve ) DSM 32583 (Bb)], were analyzed. A new bioinformatic pipeline combined with a specific infant microbiome database was used to explore shotgun metagenome datasets (1200 Megabases) for taxonomic identification and strain-level tracking. Results: Both protein forms (i.e., intact or extensively hydrolyzed protein) in IF supported infant gut microbial metabolic activity equally, as evidenced by similar levels of short-chain fatty acids (SCFAs). Interestingly, gut microbial metabolic activity was found to be differently activated in a strain-dependent manner. Taxonomic profiling of the microbiome at the strain level enabled monitoring of the prevalence and abundance of both probiotic strains, even in a complex ecosystem. Conclusion: Food matrix and host microbiota interactions should be considered when evaluating strain-specific probiotic effects in the future.
- 28 June 2024
- Published by OAE Publishing Inc. in Microbiome Research Reports
- Vol. 3 (3) , 38
Open AccessEffect of protein modification in synbiotic infant formula on probiotic metabolic activity and bacterial composition in an infant gut-model
Aim: Microbial colonization of the neonatal gut is pivotal in priming the infant’s immune system. Human milk (HM) is the best nutrition for infants and supports the development of the microbiota due to prebiotic compounds and probiotic microorganisms. When exclusive breastfeeding is not possible, infant formula (IF) with probiotics is a strategy to support the infant’s microbiome development. However, knowledge about the effects of the infant gut microbiota and different compounds in IF on individual probiotic strains is limited, as strain-level detection in a complex ecosystem is challenging. The aim of the present study was to show the effects of IF with different protein forms on the metabolic activity of two probiotic strains isolated from HM in a complex ecosystem. Methods: By using an ex-vivo infant gut model containing infant donor-microbiota, the effects of IF with either intact or extensively hydrolyzed protein on the metabolic activity of the donor microbiota, as well as two probiotic strains [Limosilactobacillus fermentum (L. fermentum ) CECT 5716 (Lf) and Bifidobacterium breve (B. breve ) DSM 32583 (Bb)], were analyzed. A new bioinformatic pipeline combined with a specific infant microbiome database was used to explore shotgun metagenome datasets (1200 Megabases) for taxonomic identification and strain-level tracking. Results: Both protein forms (i.e., intact or extensively hydrolyzed protein) in IF supported infant gut microbial metabolic activity equally, as evidenced by similar levels of short-chain fatty acids (SCFAs). Interestingly, gut microbial metabolic activity was found to be differently activated in a strain-dependent manner. Taxonomic profiling of the microbiome at the strain level enabled monitoring of the prevalence and abundance of both probiotic strains, even in a complex ecosystem. Conclusion: Food matrix and host microbiota interactions should be considered when evaluating strain-specific probiotic effects in the future.
- Open Access
- 23 April 2024
- Published by Wiley in ACR Open Rheumatology
- Vol. 6 (7) , 421-427
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
Objective: Emerging research suggests that rheumatoid arthritis (RA) is associated with intestinal dysbiosis. This prospective pilot study evaluates changes in intestinal microbial composition in patients with RA initiating treatment with either methotrexate (MTX) or a tumor necrosis factor inhibitor (TNFi).Methods: Consecutive patients, fulfilling the 2010 American College of Rheumatology/EULAR classification criteria for RA, who started treatment with either MTX or TNFi delivered a stool sample upon initiation of immunosuppression and 3 months later. A 16S ribosomal RNA gene‐based validated microbiota test (GA‐map Dysbiosis Index Score [DIS], Genetic Analysis, Oslo, Norway) was used to evaluate for the presence and degree of dysbiosis. Fecal levels of Prevotella copri (P. copri) were analyzed by custom‐made quantitative polymerase chain reaction. Changes in microbial composition were analyzed in relation to changes in disease activity, as measured by the disease activity score based on 28‐joint counts, using C‐reactive protein.Results: At baseline, dysbiosis was present in 33 of 50 (66%) participants and more common in participants with more than 2 years of disease duration (P = 0.019). At the 3‐month follow‐up, 27 of 50 (54%) were good treatment responders and the DIS had improved in 14 of 50 (28%). Participants initiating TNFi more often exhibited improvement in the DIS compared with those initiating MTX (P = 0.031). P. copri was identified in 32 of 50 (64%) at baseline. An improvement in disease activity score based on 28‐joint counts, using C‐reactive protein was associated with a simultaneous decrease in P. copri abundance (rs = 0.30, P = 0.036).Conclusion: This study affirms that dysbiosis is a feature of RA. Although patients were not randomized to MTX or TNFi, the findings suggest that specific therapies may differentially modulate the gastrointestinal microbiota in RA. The association between P. copri and treatment response requires further study.
- 23 April 2024
- Published by Wiley in ACR Open Rheumatology
- Vol. 6 (7) , 421-427
Open AccessTreatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
Objective: Emerging research suggests that rheumatoid arthritis (RA) is associated with intestinal dysbiosis. This prospective pilot study evaluates changes in intestinal microbial composition in patients with RA initiating treatment with either methotrexate (MTX) or a tumor necrosis factor inhibitor (TNFi).Methods: Consecutive patients, fulfilling the 2010 American College of Rheumatology/EULAR classification criteria for RA, who started treatment with either MTX or TNFi delivered a stool sample upon initiation of immunosuppression and 3 months later. A 16S ribosomal RNA gene‐based validated microbiota test (GA‐map Dysbiosis Index Score [DIS], Genetic Analysis, Oslo, Norway) was used to evaluate for the presence and degree of dysbiosis. Fecal levels of Prevotella copri (P. copri) were analyzed by custom‐made quantitative polymerase chain reaction. Changes in microbial composition were analyzed in relation to changes in disease activity, as measured by the disease activity score based on 28‐joint counts, using C‐reactive protein.Results: At baseline, dysbiosis was present in 33 of 50 (66%) participants and more common in participants with more than 2 years of disease duration (P = 0.019). At the 3‐month follow‐up, 27 of 50 (54%) were good treatment responders and the DIS had improved in 14 of 50 (28%). Participants initiating TNFi more often exhibited improvement in the DIS compared with those initiating MTX (P = 0.031). P. copri was identified in 32 of 50 (64%) at baseline. An improvement in disease activity score based on 28‐joint counts, using C‐reactive protein was associated with a simultaneous decrease in P. copri abundance (rs = 0.30, P = 0.036).Conclusion: This study affirms that dysbiosis is a feature of RA. Although patients were not randomized to MTX or TNFi, the findings suggest that specific therapies may differentially modulate the gastrointestinal microbiota in RA. The association between P. copri and treatment response requires further study.
- 1 January 2005
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 51 (1) , 37-44
Possible Mechanisms Behind the Differential Effects of Soy Protein and Casein Feedings on Colon Cancer Biomarkers in the Rat
In the present studies, several hypotheses were tested to explain previously reported differential effects of soy and casein on colon cancer biomarkers like cell proliferation, fecal fat, fecal bile acid, alkaline phosphatase, and magnesium excretion in rats. In Study 1, the effect of methionine, a limiting amino acid in soy protein and an amino acid that is thought to have a marked effect on colonic cell proliferation, was tested. It was concluded that methionine up to 1% in the diet had no effect on cell proliferation, using the 3H-thymidine assay. The same study revealed that fecal alkaline phosphatase excretion is a good marker for colonic epithelial damage and fecal magnesium excretion is not. In Study 2, the hypothesis was tested that soy fractions enriched with isoflavones and saponins may increase fat excretion and so influence colonic cell proliferation in rats. It was indeed shown that soy protein isolate and an ethanolic extract from soy protein isolate slightly increased fecal fat ex...
- 1 January 2005
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 51 (1) , 37-44
Possible Mechanisms Behind the Differential Effects of Soy Protein and Casein Feedings on Colon Cancer Biomarkers in the Rat
In the present studies, several hypotheses were tested to explain previously reported differential effects of soy and casein on colon cancer biomarkers like cell proliferation, fecal fat, fecal bile acid, alkaline phosphatase, and magnesium excretion in rats. In Study 1, the effect of methionine, a limiting amino acid in soy protein and an amino acid that is thought to have a marked effect on colonic cell proliferation, was tested. It was concluded that methionine up to 1% in the diet had no effect on cell proliferation, using the 3H-thymidine assay. The same study revealed that fecal alkaline phosphatase excretion is a good marker for colonic epithelial damage and fecal magnesium excretion is not. In Study 2, the hypothesis was tested that soy fractions enriched with isoflavones and saponins may increase fat excretion and so influence colonic cell proliferation in rats. It was indeed shown that soy protein isolate and an ethanolic extract from soy protein isolate slightly increased fecal fat ex...